{"nct_id":"NCT00140738","title":"Safety and Immunogenicity Study of the New dHER2 Vaccine to Treat HER2-positive Metastatic Breast Cancer","status":"COMPLETED","status_verified_date":"2019-12","start_date":"2005-03-10","start_date_type":"ACTUAL","primary_completion_date":"2008-09-29","primary_completion_date_type":"ACTUAL","completion_date":"2009-09-29","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["GSK"]}